DYT1 dystonia is caused by mutation of the TOR1A gene, resulting in the loss of a single glutamic acid residue near the carboxyl terminal of TorsinA. The neuronal functions perturbed by TorsinA[ΔE] are a major unresolved issue in understanding the pathophysiology of dystonia, presenting a critical roadblock to developing effective treatments. We identified and characterized the zebrafish homologue of TOR1A, as a first step towards elucidating the functions of TorsinA in neurons, in vivo, using the genetically-manipulable zebrafish model. The zebrafish genome was found to contain a single alternatively-spliced tor1 gene, derived from a common ancestral locus shared with the dual TOR1A and TOR1B paralogues found in tertrapods. tor1 was expressed ubiquitously during early embryonic development and in multiple adult tissues, including the CNS. The 2.1 kb tor1 mRNA encodes Torsin1, which is 59% identical and 78% homologous to human TorsinA. Torsin1 was expressed as major 45 kDa and minor 47 kDa glycoproteins, within the cytoplasm of neurons and neuropil throughout the CNS. Similar to previous findings relating to human TorsinA, mutations of the ATP hydrolysis domain of Torsin1 resulted in relocalization of the protein in cultured cells from the endoplasmic reticulum to the nuclear envelope. Zebrafish embryos lacking tor1 during early development did not show impaired viability, overt morphological abnormalities, alterations in motor behavior, or developmental defects in the dopaminergic system. Torsin1 is thus non-essential for early development of the motor system, suggesting that important CNS functions may occur later in development, consistent with the critical time window in late childhood when dystonia symptoms usually emerge in DYT1 patients. The similarities between Torsin1 and human TorsinA in domain organization, expression pattern, and cellular localization suggest that the zebrafish will provide a useful model to understand the neuronal functions of Torsins in vivo.
References
[1]
Watts RL, Koller WC (2004) Movement disorders : neurologic principles & practice. New York: McGraw-Hill. xiii, 994 p.
[2]
Kramer PL, Heiman GA, Gasser T, Ozelius LJ, de Leon D, et al. (1994) The DYT1 gene on 9q34 is responsible for most cases of early limb-onset idiopathic torsion dystonia in non-Jews. Am J Hum Genet 55: 468–475.
[3]
Ozelius LJ, Hewett JW, Page CE, Bressman SB, Kramer PL, et al. (1997) The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 17: 40–48.
[4]
Breakefield XO, Kamm C, Hanson PI (2001) TorsinA: movement at many levels. Neuron 31: 9–12.
[5]
Hanson PI, Whiteheart SW (2005) AAA+ proteins: have engine, will work. Nat Rev Mol Cell Biol 6: 519–529.
[6]
Hewett JW, Zeng J, Niland BP, Bragg DC, Breakefield XO (2006) Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics. Neurobiol Dis 22: 98–111.
[7]
Granata A, Watson R, Collinson LM, Schiavo G, Warner TT (2008) The dystonia-associated protein torsinA modulates synaptic vesicle recycling. J Biol Chem 283: 7568–7579.
[8]
Hewett JW, Tannous B, Niland BP, Nery FC, Zeng J, et al. (2007) Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc Natl Acad Sci U S A 104: 7271–7276.
[9]
Torres GE, Sweeney AL, Beaulieu JM, Shashidharan P, Caron MG (2004) Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci U S A 101: 15650–15655.
[10]
Augood SJ, Penney JB Jr, Friberg IK, Breakefield XO, Young AB, et al. (1998) Expression of the early-onset torsion dystonia gene (DYT1) in human brain. Ann Neurol 43: 669–673.
[11]
Hewett J, Gonzalez-Agosti C, Slater D, Ziefer P, Li S, et al. (2000) Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum Mol Genet 9: 1403–1413.
[12]
Goodchild RE, Dauer WT (2004) Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc Natl Acad Sci U S A 101: 847–852.
[13]
Babst M, Wendland B, Estepa EJ, Emr SD (1998) The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function. EMBO J 17: 2982–2993.
[14]
Weibezahn J, Schlieker C, Bukau B, Mogk A (2003) Characterization of a trap mutant of the AAA+ chaperone ClpB. J Biol Chem 278: 32608–32617.
[15]
Naismith TV, Heuser JE, Breakefield XO, Hanson PI (2004) TorsinA in the nuclear envelope. Proc Natl Acad Sci U S A 101: 7612–7617.
[16]
Naismith TV, Dalal S, Hanson PI (2009) Interaction of torsinA with its major binding partners is impaired by the dystonia-associated DeltaGAG deletion. J Biol Chem 284: 27866–27874.
[17]
Breakefield XO, Blood AJ, Li Y, Hallett M, Hanson PI, et al. (2008) The pathophysiological basis of dystonias. Nat Rev Neurosci 9: 222–234.
[18]
Basham SE, Rose LS (1999) Mutations in ooc-5 and ooc-3 disrupt oocyte formation and the reestablishment of asymmetric PAR protein localization in two-cell Caenorhabditis elegans embryos. Dev Biol 215: 253–263.
[19]
Muraro NI, Moffat KG (2006) Down-regulation of torp4a, encoding the Drosophila homologue of torsinA, results in increased neuronal degeneration. J Neurobiol 66: 1338–1353.
[20]
Wakabayashi-Ito N, Doherty OM, Moriyama H, Breakefield XO, Gusella JF, et al. (2011) Dtorsin, the Drosophila ortholog of the early-onset dystonia TOR1A (DYT1), plays a novel role in dopamine metabolism. PLoS One 6: e26183.
[21]
Dang MT, Yokoi F, McNaught KS, Jengelley TA, Jackson T, et al. (2005) Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia. Exp Neurol 196: 452–463.
[22]
Goodchild RE, Kim CE, Dauer WT (2005) Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 48: 923–932.
[23]
Grundmann K, Reischmann B, Vanhoutte G, Hubener J, Teismann P, et al. (2007) Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities. Neurobiol Dis 27: 190–206.
[24]
Page ME, Bao L, Andre P, Pelta-Heller J, Sluzas E, et al. (2010) Cell-autonomous alteration of dopaminergic transmission by wild type and mutant (DeltaE) TorsinA in transgenic mice. Neurobiol Dis 39: 318–326.
[25]
Sharma N, Baxter MG, Petravicz J, Bragg DC, Schienda A, et al. (2005) Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J Neurosci 25: 5351–5355.
[26]
Shashidharan P, Sandu D, Potla U, Armata IA, Walker RH, et al. (2005) Transgenic mouse model of early-onset DYT1 dystonia. Hum Mol Genet 14: 125–133.
[27]
Yokoi F, Dang MT, Mitsui S, Li J, Li Y (2008) Motor deficits and hyperactivity in cerebral cortex-specific Dyt1 conditional knockout mice. J Biochem 143: 39–47.
[28]
Balcioglu A, Kim MO, Sharma N, Cha JH, Breakefield XO, et al. (2007) Dopamine release is impaired in a mouse model of DYT1 dystonia. J Neurochem 102: 783–788.
[29]
Martella G, Tassone A, Sciamanna G, Platania P, Cuomo D, et al. (2009) Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain 132: 2336–2349.
[30]
Sager JJ, Bai Q, Burton EA (2010) Transgenic zebrafish models of neurodegenerative diseases. Brain Struct Funct 214: 285–302.
[31]
Del Bene F, Wyart C (2011) Optogenetics: A new enlightenment age for zebrafish neurobiology. Dev Neurobiol.
[32]
Raz E, Zlokarnik G, Tsien RY, Driever W (1998) beta-lactamase as a marker for gene expression in live zebrafish embryos. Dev Biol 203: 290–294.
[33]
Andersen E, Asuri N, Clay M, Halloran M (2010) Live imaging of cell motility and actin cytoskeleton of individual neurons and neural crest cells in zebrafish embryos. J Vis Exp.
[34]
Rihel J, Prober DA, Arvanites A, Lam K, Zimmerman S, et al. (2010) Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 327: 348–351.
[35]
Levin ED, Cerutti DT (2009) Behavioral Neuroscience of Zebrafish. In: Buccafusco JJ, editor. Methods of Behavior Analysis in Neuroscience. 2nd ed. Boca Raton (FL).
[36]
Arrenberg AB, Del Bene F, Baier H (2009) Optical control of zebrafish behavior with halorhodopsin. Proc Natl Acad Sci U S A 106: 17968–17973.
[37]
Wyart C, Del Bene F, Warp E, Scott EK, Trauner D, et al. (2009) Optogenetic dissection of a behavioural module in the vertebrate spinal cord. Nature 461: 407–410.
[38]
Bretaud S, Allen C, Ingham PW, Bandmann O (2007) p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson’s disease. J Neurochem 100: 1626–1635.
[39]
Flinn L, Mortiboys H, Volkmann K, Koster RW, Ingham PW, et al. (2009) Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). Brain 132: 1613–1623.
[40]
Lumsden AL, Henshall TL, Dayan S, Lardelli MT, Richards RI (2007) Huntingtin-deficient zebrafish exhibit defects in iron utilization and development. Hum Mol Genet 16: 1905–1920.
[41]
Issa FA, Mazzochi C, Mock AF, Papazian DM (2011) Spinocerebellar ataxia type 13 mutant potassium channel alters neuronal excitability and causes locomotor deficits in zebrafish. J Neurosci 31: 6831–6841.
[42]
Panula P, Chen YC, Priyadarshini M, Kudo H, Semenova S, et al. (2010) The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis 40: 46–57.
[43]
Stephenson-Jones M, Samuelsson E, Ericsson J, Robertson B, Grillner S (2011) Evolutionary conservation of the basal ganglia as a common vertebrate mechanism for action selection. Curr Biol 21: 1081–1091.
[44]
Bai Q, Garver JA, Hukriede NA, Burton EA (2007) Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene. Nucleic Acids Res 35: 6501–6516.
[45]
Bai Q, Mullett SJ, Garver JA, Hinkle DA, Burton EA (2006) Zebrafish DJ-1 is evolutionarily conserved and expressed in dopaminergic neurons. Brain Res 1113: 33–44.
[46]
Bai Q, Wei X, Burton EA (2009) Expression of a 12-kb promoter element derived from the zebrafish enolase-2 gene in the zebrafish visual system. Neurosci Lett 449: 252–257.
[47]
Bai Q, Sun M, Stolz DB, Burton EA (2011) Major isoform of zebrafish P0 is a 23.5 kDa myelin glycoprotein expressed in selected white matter tracts of the central nervous system. J Comp Neurol 519: 1580–1596.
[48]
Choi HK, Won LA, Kontur PJ, Hammond DN, Fox AP, et al. (1991) Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res 552: 67–76.
[49]
Nasevicius A, Ekker SC (2000) Effective targeted gene ‘knockdown’ in zebrafish. Nat Genet 26: 216–220.
[50]
Cario CL, Farrell TC, Milanese C, Burton EA (2011) Automated measurement of zebrafish larval movement. J Physiol 589: 3703–3708.
[51]
Farrell TC, Cario CL, Milanese C, Vogt A, Jeong JH, et al. (2011) Evaluation of spontaneous propulsive movement as a screening tool to detect rescue of Parkinsonism phenotypes in zebrafish models. Neurobiol Dis 44: 9–18.
[52]
Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947–2948.
[53]
Drummond AJ, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214.
[54]
Ozelius LJ, Page CE, Klein C, Hewett JW, Mineta M, et al. (1999) The TOR1A (DYT1) gene family and its role in early onset torsion dystonia. Genomics 62: 377–384.
[55]
Schug J, Schuller WP, Kappen C, Salbaum JM, Bucan M, et al. (2005) Promoter features related to tissue specificity as measured by Shannon entropy. Genome Biol 6: R33.
[56]
Whiteheart SW, Rossnagel K, Buhrow SA, Brunner M, Jaenicke R, et al. (1994) N-ethylmaleimide-sensitive fusion protein: a trimeric ATPase whose hydrolysis of ATP is required for membrane fusion. J Cell Biol 126: 945–954.
[57]
Callan AC, Bunning S, Jones OT, High S, Swanton E (2007) Biosynthesis of the dystonia-associated AAA+ ATPase torsinA at the endoplasmic reticulum. Biochem J 401: 607–612.
[58]
Bai Q, Burton EA (2009) Cis-acting elements responsible for dopaminergic neuron-specific expression of zebrafish slc6a3 (dopamine transporter) in vivo are located remote from the transcriptional start site. Neuroscience 164: 1138–1151.
[59]
Holzschuh J, Ryu S, Aberger F, Driever W (2001) Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo. Mech Dev 101: 237–243.
[60]
Milanese C, Sager JJ, Bai Q, Farrell TC, Cannon JR, et al. (2012) Hypokinesia and reduced dopamine levels in zebrafish lacking beta- and gamma1-synucleins. J Biol Chem 287: 2971–2983.
[61]
Kim CE, Perez A, Perkins G, Ellisman MH, Dauer WT (2010) A molecular mechanism underlying the neural-specific defect in torsinA mutant mice. Proc Natl Acad Sci U S A 107: 9861–9866.
[62]
Kafri R, Springer M, Pilpel Y (2009) Genetic redundancy: new tricks for old genes. Cell 136: 389–392.
[63]
Saper CB (2005) An open letter to our readers on the use of antibodies. J Comp Neurol 493: 477–478.
